Efficacy of vitamins supplementation to therapy on Helicobacter pylori eradication in patients with low antioxidant capacity

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 11, 2011, Pages 745-749

  Sezikli, Mesut ^a   Çetinkaya, Züleyha Akkan ^a   Güzelbulut, Fatih ^b   Sezikli, Hayrünnisa ^b   Özkara, Selvinaz ^b   Coşgun, Süleyman ^b   Gönen, Can ^b   Övünç, Ayşe Oya Kurdaş ^b  

^a Kocaeli Derince Education and Research Hospital   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; ANTIOXIDANT; ASCORBIC ACID; CLARITHROMYCIN; LANSOPRAZOLE;

ADULT; ARTICLE; CHRONIC STRESS; CONTROLLED STUDY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; VITAMIN SUPPLEMENTATION;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; DIETARY SUPPLEMENTS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; VITAMIN E;

EID: 83155175314     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.07.001     Document Type: Article

References (25)

1. Pounder R.E., Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995, 9:33-39.
2. Marshall B.J., Barry J. Helicobacter pylori and peptic ulcer. JAMA 1995, 274:1064-1066.
3. Parsonnet J., Hansen S., Rodriguez L., Gelb A.B., Warnke R.A., Jellum E., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994, 330:1267-1271.
4. Dooley C.P., Cohen H., Fitzgibbons P.L., Bauer M., Appleman M.D., Perez-Perez G.I., et al. Prevalance of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 1986, 321:1562-1566.
5. Mobley H.L.T. Defining Helicobacter pylori as a pathogen: strain heterogeneity and virulence. Am J Med 1996, 100:2S-9S.
6. Sezikli M., Akkan çetinkaya Z., Sezikli H., Güzelbulut F., Tiftikçi A., Ince A.T., et al. Oxidative stress in Helicobacter pylori infection: does supplementation with vitamins C and E increase the eradication rate?. Helicobacter 2009, 14:280-285.
7. Demir M., Göktürk S., Ozturk N.A., Serin E., Yilmaz U. Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients. Digestion 2010, 82:47-53.
8. Demir M., Göktürk H.S., Ozturk N.A., Arslan H., Serin E., Yilmaz U. Clarithromycin resistance and efficacy of clarithromycin-containing triple eradication therapy for Helicobacter pylori infection in type 2 diabetes mellitus patients. South Med J 2009, 102:1116-1120.
9. Suzuki T., Matsuo K., Ito H., Sawaki A., Hirose K., Wakai K., et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 2006, 119:217-224.
10. Naito Y., Yoshikawa T. Molecular and cellular mechanisms involved in H. pylori-induced inflammation and oxidative stress. Free Radic Biol Med 2002, 33:323-336.
11. Ernst P. Review article: the role of inflammation in the pathogenesis of gastric cancer. Aliment Pharmacol Ther 1999, 13:13-18.
12. O'Toole P., Lombard M. Vitamin C and gastric cancer: supplements for some or fruit for all?. Gut 1996, 39:345-347.
13. Wang X., Willen R., Wadström T. Astaxanthinrich algal meal and vitamin C inhibit H. pylori infection in BALB/cA mice. Antimicrob Agents Chemother 2000, 44:2452-2457.
14. Sjunnesson H., Sturegård E., Willen R., Wadström T. High intake of selenium, beta-carotene, and vitamins A, C, and E reduces growth of H. pylori in the guinea pig. Comp Med 2001, 51:418-423.
15. Sun Y.Q., Girgensone I., Leanderson P., Petersson F., Borch K. Effects of antioxidant vitamin supplements on Helicobacter pylori-induced gastritis in Mongolian gerbils. Helicobacter 2005, 10:33-42.
16. Zhang Z.W., Patchett S.E., Perrett D., Katelaris P.H., Domizio P., Farthing M.J.G. The relation between gastric vitamin C concentrations, mucosal histology, and CagA seropositivity in the human stomach. Gut 1998, 43:322-326.
17. Zhang H.M., Wakisaka N., Maeda O., Yamamoto T. Vitamin C inhibits the growth of a bacterial risk factor for gastric carcinoma: H. pylori. Cancer 1997, 80:1897-1902.
18. Rokkas T., Papatheodorou G., Karameris A., Marrogeorgis A., Kalogeropoulos N., Giannikos N. H. pylori infection and gastric juice vitamin C levels: impact of eradication. Dig Dis Sci 1995, 40:615-621.
19. Phull P.S., Price A.B., Thormiley M.S., Green C.J., Jacyna M.R. Vitamin E concentrations in the human stomach and duodenum-correlation with H. pylori infection. Gut 1996, 39:31-35.
20. Plummer M., Vivas J., Lopez G., Bravo J.C., Peraza S., Carillo E., et al. Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation: a randomized trial in a high-risk population. J Natl Cancer Inst 2007, 99:137-146.
21. Camargo J.L., Stifft J., Gross J.L. The effect of aspirin and vitamins C and E on HbA1c assays. Clin Chim Acta 2006, 372:206-209.
22. Afkhami-Ardekani M., Shojaoddiny-Ardekani A. Effect of vitamin C on blood glucose, serum lipids & serum insulin in type 2 diabetes patients. Indian J Med Res 2007, 126:471-474.
23. Chen H., Karne R.J., Hall G., Campia U., Panza J.A., Cannon R.O., et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with Type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol 2006, 290:137-145.
24. Chuang C.H., Sheu B.S., Huang A.H., Yang H.B., Wu J.J. Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection. Helicobacter 2002, 7:310-316.
25. Chuang C.H., Sheu B.S., Kao A.W., Cheng H.C., Huang A.H., Yang H.B., et al. Adjuvant effect of vitamin C on omeprazole-amoxicillin-clarithromycin triple therapy for Helicobacter pylori eradication. Hepatogastroenterology 2007, 54:320-324.